About This Calculator

The Magnesium Sulfate Preeclampsia Dose Calculator is a clinical tool designed for healthcare professionals to determine appropriate loading and maintenance doses of MgSO₄ for seizure prophylaxis in patients with preeclampsia with severe features or eclampsia. This tool simplifies dose calculation according to established, evidence-based protocols.

Calculator Outputs

After entering the required patient data, the calculator provides the following key outputs:

• Loading Dose: The initial bolus dose of magnesium sulfate, specified in grams, along with the recommended route (IV or IV/IM) and administration instructions.
• Maintenance Dose: The subsequent dose administered to maintain therapeutic magnesium levels. This is provided as an hourly rate for continuous infusions (Zuspan protocol) or a fixed dose at regular intervals for IM administration (Pritchard protocol).
• Adjusted Dosing: If renal impairment is indicated, the calculator automatically reduces the maintenance dose to minimize the risk of toxicity.
• IV Infusion Rate (Optional): If IV bag concentration is provided, the calculator computes the precise infusion pump rate in mL/hour to deliver the correct hourly maintenance dose.

How to Use the Calculator

Follow these steps to ensure accurate dose calculation:

1. Enter Patient Weight: Input the patient’s weight and select the correct unit (kg or lbs). The calculator converts lbs to kg for dosing calculations.
2. Select Dosing Protocol: Choose between the Zuspan (IV only) or Pritchard (IV/IM) protocol based on clinical context and institutional guidelines.
3. Indicate Renal Function: Check the “Renal impairment” box if the patient has evidence of renal dysfunction (e.g., serum creatinine >1.2 mg/dL or oliguria). This will adjust the maintenance dose.
4. Calculate IV Infusion Rate (Optional): For continuous IV maintenance, enter the total grams of MgSO₄ in the IV bag and the total fluid volume (in mL) to calculate the pump rate.
5. Review Results: The calculator will display the recommended loading and maintenance doses. Always verify calculations and cross-reference with institutional protocols and clinical judgment.

Dosing Overview

The calculator is based on two primary protocols for magnesium sulfate administration in severe preeclampsia and eclampsia:

• Zuspan Protocol: An intravenous-only regimen. It consists of a 4-gram IV loading dose infused over 20-30 minutes, followed by a continuous maintenance infusion of 1-2 grams per hour. The standard maintenance dose is 2 g/hr, which is halved to 1 g/hr in cases of renal impairment.
• Pritchard Protocol: A combined intravenous and intramuscular regimen. It involves a 4-gram IV loading dose plus a 10-gram deep IM loading dose (5g in each buttock). This is followed by a maintenance dose of 5 grams IM every 4 hours. The maintenance dose is halved to 2.5g in cases of renal impairment.

Managing Interrupted Doses

An interruption in magnesium sulfate therapy requires immediate clinical assessment. If a maintenance dose is delayed or an infusion is stopped, consult institutional protocols. This may involve assessing the patient’s clinical status, checking serum magnesium levels, and deciding whether to restart the infusion at the previous rate or administer a small bolus. For a delayed IM dose in the Pritchard protocol, administer the dose as soon as possible and adjust the subsequent schedule, ensuring close monitoring for toxicity. Never “double up” on doses.

Switching Protocols

Switching between the Zuspan and Pritchard protocols mid-treatment is not a standard practice and should only be done under the direction of a senior clinician. A change in therapy might be considered due to issues like lack of IV access (necessitating a switch to IM) or patient intolerance to IM injections. Any such change requires a careful recalculation of subsequent doses to avoid sub-therapeutic levels or toxicity.

Safety Alerts

Frequently Asked Questions

What is the primary difference between the Zuspan and Pritchard protocols?
The main difference is the route of administration for the maintenance dose. Zuspan uses a continuous IV infusion, which provides steady serum levels but requires an infusion pump and constant IV access. Pritchard uses intermittent deep IM injections, which can be useful if IV access is difficult but may be more painful for the patient.

How does renal impairment affect magnesium sulfate dosing?
Magnesium is cleared by the kidneys. In patients with renal impairment, the maintenance dose is typically reduced by 50% to prevent accumulation and toxicity. The loading dose generally remains unchanged as it is needed to quickly establish therapeutic levels.

What are the first signs of magnesium toxicity to monitor for?
The earliest and most common sign is the loss of deep tendon reflexes (DTRs), particularly the patellar reflex. This is why DTRs are checked frequently during administration.

Why is the IV infusion rate calculation useful?
It translates the prescribed hourly dose (in grams/hour) into a practical pump setting (in mL/hour) based on the specific concentration of the IV solution being used, reducing the risk of medication errors.

What is the therapeutic serum magnesium level for seizure prophylaxis?
The target therapeutic range is generally considered to be 4.8 to 8.4 mg/dL (4 to 7 mEq/L).

Is patient weight used to calculate the dose?
No, standard protocols for preeclampsia use fixed doses for loading and maintenance that are not weight-based. However, patient weight is a critical demographic, and the calculator includes it for complete record-keeping and clinical context.

Can this calculator be used for preeclampsia without severe features?
The use of magnesium sulfate for preeclampsia without severe features is not universally recommended and depends on clinical judgment and specific patient factors. This calculator is designed for use in patients with severe features or eclampsia, as recommended by ACOG.

What is the antidote for magnesium toxicity?
The antidote is Calcium Gluconate. The standard dose is 1 gram (10 mL of a 10% solution) administered slowly via IV push.